1/5
04:31 pm
iart
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/25
06:33 am
iart
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? [Yahoo! Finance]
Low
Report
At US$12.66, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely? [Yahoo! Finance]
12/18
07:18 am
iart
ATS Corp. to make normal course issuer bid [Seeking Alpha]
Low
Report
ATS Corp. to make normal course issuer bid [Seeking Alpha]
12/16
04:38 pm
iart
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/1
05:32 pm
iart
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference [Yahoo! Finance]
Low
Report
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference [Yahoo! Finance]
12/1
04:30 pm
iart
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
Low
Report
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
11/26
02:09 pm
iart
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
08:30 am
iart
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
Medium
Report
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
11/17
03:47 am
iart
Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) [Yahoo! Finance]
Low
Report
Surgical Equipment & Consumables - Specialty Stocks Q3 Recap: Benchmarking Integra LifeSciences (NASDAQ:IART) [Yahoo! Finance]
11/14
01:15 pm
iart
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Integra LifeSciences (NASDAQ:IART) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/13
03:17 pm
iart
Integra LifeSciences (IART) Stock Trades Up, Here Is Why [Yahoo! Finance]
Neutral
Report
Integra LifeSciences (IART) Stock Trades Up, Here Is Why [Yahoo! Finance]
11/11
04:37 pm
iart
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries [Yahoo! Finance]
Medium
Report
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries [Yahoo! Finance]
11/11
04:15 pm
iart
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
Neutral
Report
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
11/6
02:51 am
iart
5 Must-Read Analyst Questions From Integra LifeSciences's Q3 Earnings Call [Yahoo! Finance]
Low
Report
5 Must-Read Analyst Questions From Integra LifeSciences's Q3 Earnings Call [Yahoo! Finance]
11/3
10:42 am
iart
Integra LifeSciences (NASDAQ:IART) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $13.00 price target on the stock, down previously from $15.00.
Medium
Report
Integra LifeSciences (NASDAQ:IART) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $13.00 price target on the stock, down previously from $15.00.
10/31
04:42 pm
iart
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Medium
Report
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
10/31
02:43 pm
iart
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
Medium
Report
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
10/30
06:00 am
iart
Integra LifeSciences Reports Third Quarter 2025 Financial Results
High
Report
Integra LifeSciences Reports Third Quarter 2025 Financial Results